Integrated transcriptomic analysis, serum cytokine profiling, and lung tumor analysis revealed significant enrichment of immune activation and immune cell-mediated cytotoxicity pathways, indicating that HVEM-Fc can activate anti-tumor immunity involving macrophages, natural killer cells, and CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.